期刊文献+

慢性HCV感染与原发性肝癌 被引量:3

下载PDF
导出
摘要 丙型肝炎病毒(hepatitis C virus,HCV)感染是世界范围内慢性肝脏疾病的主要原因之一,预计全球范围内HCV慢性感染人群约1.8亿。慢性HCV感染20年后约5%~15%的患者将进展为肝硬化,肝硬化患者每年肝癌的发生率为2%~4%。
出处 《医学研究杂志》 2017年第11期1-3,53,共4页 Journal of Medical Research
基金 中华医学会临床医学科研专项基金资助项目(13071110496) 北京医学奖励基金资助项目(42411040D)
  • 相关文献

参考文献1

二级参考文献15

  • 1Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection[ J]. Nat Rev Gastroenterol Hepatol, 2013, 10(9) : 553 -562. 被引量:1
  • 2Wang FS, Fan JG, Zhang Z, et al. The global burden of liver dis- ease: the major impact of China [ J ]. Hepatology, 2014, 60 ( 6 ) : 2099 - 2108. 被引量:1
  • 3Chen JG, Zhang SW. Liver cancer epidemic in China: past, present and future[J]. Semin Cancer Biol, 2011, 21(1): 59 -69. 被引量:1
  • 4Davis GL, Balart LA, Sehiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, con- trolled trial. Hepatitis lnterventional Therapy Group [ J ]. N Engl J Med, 1989, 321(22) :1501 - 1506. 被引量:1
  • 5Poynard T, Bedossa P, Chevallier M, et al. A comparison of three in- terferon alfa - 2b regimens for the long - term treatment of chronic non - A, non - B hepatitis. Multicenter Study Group [ J]. N Engl J Med,1995, 332(22) :1457 - 1462. 被引量:1
  • 6McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa - 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group [ J ]. N Engl J Med, 1998, 339(21) :1485-1492. 被引量:1
  • 7Poynard T, Marcellin P, Lee SS, et al. Randomised trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventioual Therapy Group (IHIT) [ J ]. Lancet, 1998, 352(9138) : 1426 - 1432. 被引量:1
  • 8Lu L, Nakano T, He Y, et al. Hepatitis C virus genotype distribution in China: predominance of closely related subtype lb isolates and ex- istence of new genotype 6 variants[ J ]. J Med Virol, 2005, 75 (4) : 538 - 549. 被引量:1
  • 9Poordad F, Mccone J Jr, Bacon BR, et al. Boceprevir for untreated chronic HCV genotype 1 infection [ J]. N Engl J Med, 2011, 364 (13) :1195 - 1206. 被引量:1
  • 10Jaeobson IM, McHutchison JG, Dushieiko G, et al. Telaprevir for previously untreated chronic hepatitis C virus infection[ J]. N Engl J Med, 2011, 364 (25) :2405 - 2416. 被引量:1

共引文献7

同被引文献22

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部